769 related articles for article (PubMed ID: 28034979)
1. Efficacy and Safety of Tanezumab on Osteoarthritis Knee and Hip Pains: A Meta-Analysis of Randomized Controlled Trials.
Chen J; Li J; Li R; Wang H; Yang J; Xu J; Zha Z
Pain Med; 2017 Feb; 18(2):374-385. PubMed ID: 28034979
[TBL] [Abstract][Full Text] [Related]
2. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials.
Wang ZY; Shi SY; Li SJ; Chen F; Chen H; Lin HZ; Lin JM
Pain Med; 2015 Jul; 16(7):1373-85. PubMed ID: 26176791
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of tanezumab administered as a fixed dosing regimen in patients with knee or hip osteoarthritis: a meta-analysis of randomized controlled phase III trials.
Fan ZR; Ma JX; Wang Y; Chen HT; Lang S; Ma XL
Clin Rheumatol; 2021 Jun; 40(6):2155-2165. PubMed ID: 33159281
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxen.
Ekman EF; Gimbel JS; Bello AE; Smith MD; Keller DS; Annis KM; Brown MT; West CR; Verburg KM
J Rheumatol; 2014 Nov; 41(11):2249-59. PubMed ID: 25274899
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
[TBL] [Abstract][Full Text] [Related]
7. Relative Efficacy and Safety of Tanezumab for Osteoarthritis: A Systematic Review and Meta-analysis of Randomized-Controlled Trials.
Zhang B; Tian X; Qu Z; Liu J; Yang L
Clin J Pain; 2021 Dec; 37(12):914-924. PubMed ID: 34608021
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period.
Berenbaum F; Blanco FJ; Guermazi A; Miki K; Yamabe T; Viktrup L; Junor R; Carey W; Brown MT; West CR; Verburg KM
Ann Rheum Dis; 2020 Jun; 79(6):800-810. PubMed ID: 32234715
[TBL] [Abstract][Full Text] [Related]
9. Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial.
Brown MT; Murphy FT; Radin DM; Davignon I; Smith MD; West CR
Arthritis Rheum; 2013 Jul; 65(7):1795-803. PubMed ID: 23553790
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
Schnitzer TJ; Ekman EF; Spierings EL; Greenberg HS; Smith MD; Brown MT; West CR; Verburg KM
Ann Rheum Dis; 2015 Jun; 74(6):1202-11. PubMed ID: 24625625
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial.
Hochberg MC; Carrino JA; Schnitzer TJ; Guermazi A; Walsh DA; White A; Nakajo S; Fountaine RJ; Hickman A; Pixton G; Viktrup L; Brown MT; West CR; Verburg KM
Arthritis Rheumatol; 2021 Jul; 73(7):1167-1177. PubMed ID: 33538113
[TBL] [Abstract][Full Text] [Related]
12. Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study.
Neogi T; Hunter DJ; Churchill M; Shirinsky I; White A; Guermazi A; Omata M; Fountaine RJ; Pixton G; Viktrup L; Brown MT; West CR; Verburg KM
Arthritis Res Ther; 2022 Mar; 24(1):78. PubMed ID: 35351194
[TBL] [Abstract][Full Text] [Related]
13. Tanezumab for Patients with Osteoarthritis of the Knee: A Meta-Analysis.
Kan SL; Li Y; Ning GZ; Yuan ZF; Chen LX; Bi MC; Sun JC; Feng SQ
PLoS One; 2016; 11(6):e0157105. PubMed ID: 27294371
[TBL] [Abstract][Full Text] [Related]
14. Based on minimal clinically important difference values, a moderate dose of tanezumab may be a better option for treating hip or knee osteoarthritis: a meta-analysis of randomized controlled trials.
Zhao D; Luo MH; Pan JK; Zeng LF; Liang GH; Han YH; Liu J; Yang WY
Ther Adv Musculoskelet Dis; 2022; 14():1759720X211067639. PubMed ID: 35069811
[TBL] [Abstract][Full Text] [Related]
15. Safety of Low-Dose Tanezumab in the Treatment of Hip or Knee Osteoarthritis: A Systemic Review and Meta-analysis of Randomized Phase III Clinical Trials.
Yu Y; Lu ST; Sun JP; Zhou W
Pain Med; 2021 Mar; 22(3):585-595. PubMed ID: 33141224
[TBL] [Abstract][Full Text] [Related]
16. Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study.
Schnitzer TJ; Khan A; Bessette L; Davignon I; Brown MT; Pixton G; Prucka WR; Tive L; Viktrup L; West CR
Semin Arthritis Rheum; 2020 Jun; 50(3):387-393. PubMed ID: 32252976
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee.
Schnitzer TJ; Marks JA
Osteoarthritis Cartilage; 2015 Jan; 23 Suppl 1():S8-17. PubMed ID: 25527221
[TBL] [Abstract][Full Text] [Related]
18. A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee.
Spierings ELH; Fidelholtz J; Wolfram G; Smith MD; Brown MT; West CR
Pain; 2013 Sep; 154(9):1603-1612. PubMed ID: 23707270
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Various Dosages and Administration Methods of Tanezumab for the Treatment of Pain in Knee and Hip Osteoarthritis: a Network Meta-Analysis.
Cai YZ; Nie LY; Ruan JQ; Zhao K
Clin Ther; 2021 Dec; 43(12):2116-2126. PubMed ID: 34819241
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intra-articular hyaluronic acid and methylprednisolone for pain management in knee osteoarthritis: A meta-analysis of randomized controlled trials.
Ran J; Yang X; Ren Z; Wang J; Dong H
Int J Surg; 2018 May; 53():103-110. PubMed ID: 29574247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
